Analytical Data
-
基因名
Carboxylesterase
- Application
-
别名
Carboxylesterase; Thermobifida fusca; Thermomonospora fusca; Hydrolase; Serine esterase; 3.1.1.1
-
种属
Others
-
表达系统
E. coli
-
标签
His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P86325
-
表达区间
M1-L497
-
蛋白长度
Full Length
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Carboxylesterases (CEs) are a group of enzymes that play a crucial role in the hydrolysis of ester bonds in various substrates, including drugs, xenobiotics, and endogenous compounds. These enzymes are significant in pharmacology and toxicology due to their ability to metabolize a wide range of drugs, influencing drug efficacy and safety. Recent studies have highlighted the role of CEs in drug resistance and the metabolic activation of prodrugs, making them a focal point in drug development and personalized medicine. With advancements in recombinant DNA technology, researchers have begun to produce and manipulate carboxylesterase proteins to better understand their structure-function relationships and catalytic mechanisms. The ability to generate recombinant CEs allows for in-depth studies into their substrate specificity, enzymatic activity, and potential applications in bioremediation and biotransformation processes. Furthermore, the exploration of genetically engineered variants of carboxylesterases holds promise for enhancing their catalytic efficiency and stability, providing valuable tools in pharmaceutical applications. Overall, the growing interest in carboxylesterases as therapeutic targets and biocatalysts underscores their importance in biochemical research, making them a key focus for future investigations in enzymology and drug metabolism.












